关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Tianjin

Release time:

2017-01-03

Product name Specifications Conversion ratio
Fenofibrate Capsules 0.2g 10
Diammonium glycyrrhizinate enteric-coated tablets 50mg 24
Guipi Capsule 0.3g per capsule 36
Guipi Capsule 0.3g per capsule 24
Sodium ferulate for injection 0.1g 1
Sodium creatine phosphate for injection 0.5g (calculated as C4H8N3Na2O5P) 1
Sodium creatine phosphate for injection 1.0g (according to C4H8N3Na2O5P) 1
Cefoxitin Sodium for Injection Based on C16H17N307S2 calculation 0.5g 1
Clindamycin hydrochloride for injection 0.15g (as clindamycin) 1
Azithromycin for Injection 0.5g 1
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs